IL81676A - Naphthothiazepinones,their manufacture and medicaments containing them - Google Patents

Naphthothiazepinones,their manufacture and medicaments containing them

Info

Publication number
IL81676A
IL81676A IL81676A IL8167687A IL81676A IL 81676 A IL81676 A IL 81676A IL 81676 A IL81676 A IL 81676A IL 8167687 A IL8167687 A IL 8167687A IL 81676 A IL81676 A IL 81676A
Authority
IL
Israel
Prior art keywords
naphthothiazepinones
manufacture
medicaments containing
medicaments
Prior art date
Application number
IL81676A
Other languages
English (en)
Other versions
IL81676A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL81676A0 publication Critical patent/IL81676A0/xx
Publication of IL81676A publication Critical patent/IL81676A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
IL81676A 1986-02-26 1987-02-25 Naphthothiazepinones,their manufacture and medicaments containing them IL81676A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/834,178 US4652561A (en) 1986-02-26 1986-02-26 Naphtho[1,2-b]-1,4-thiazepinones

Publications (2)

Publication Number Publication Date
IL81676A0 IL81676A0 (en) 1987-09-16
IL81676A true IL81676A (en) 1991-03-10

Family

ID=25266290

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81676A IL81676A (en) 1986-02-26 1987-02-25 Naphthothiazepinones,their manufacture and medicaments containing them

Country Status (16)

Country Link
US (1) US4652561A (xx)
EP (1) EP0234561A3 (xx)
JP (1) JPS62205067A (xx)
KR (1) KR900003369B1 (xx)
AU (1) AU594124B2 (xx)
CA (1) CA1272717A (xx)
DK (1) DK93787A (xx)
FI (1) FI870796A (xx)
HU (1) HU197732B (xx)
IL (1) IL81676A (xx)
MC (1) MC1792A1 (xx)
NO (1) NO167285C (xx)
NZ (1) NZ219386A (xx)
PH (1) PH23214A (xx)
PT (1) PT84358B (xx)
ZA (1) ZA871144B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61939B1 (en) * 1987-07-31 1994-11-30 Tanabe Seiyaku Co Naphthothiazepine derivatives and a process for preparing the same
US4808580A (en) * 1987-12-17 1989-02-28 Hoffmann-La Roche Inc. Naphtho[1,2-b][1,4]thiazepin-4(5H)-ones and use thereof in treatment of ischemia and blood pressure lowering
US4912102A (en) * 1988-02-01 1990-03-27 Hoffmann-La Roche Inc. Analogs of naphtho[1,2-β] [1,4] thiazepin-4(5H)-one
US4996352A (en) * 1988-05-10 1991-02-26 Hoffmann-La Roche Inc. Enantiomers of β-[(2-amino-1-naphthalenyl) thiol]-α-hydroxy-4-methoxybenzene propanoic acid
US4864058A (en) * 1988-05-10 1989-09-05 Hoffmann-La Roche Inc. Process for making optically active naphtho[1,2-b][1,4]thiazepin-4(5H)-ones
US5225557A (en) * 1988-05-10 1993-07-06 Hoffmann-La Roche Inc. Process for making optically active naphtho[1,2-b]thiazepin-4(5H)-ones
ZA893392B (en) * 1988-05-24 1990-01-31 Hoffmann La Roche Process for the manufacture of optically active naphthothiazepinones
US5008411A (en) * 1988-05-24 1991-04-16 Hoffmann-La Roche Inc. Glycidic acid ester and process of preparation
JPH0637480B2 (ja) * 1988-10-29 1994-05-18 田辺製薬株式会社 ナフトチアゼピン誘導体
GB9315566D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Medicaments
GB9315600D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Compounds
KR100707050B1 (ko) * 2002-11-28 2007-04-13 에스케이 주식회사 10Ｈ-디벤조[ｂ,ｆ][1,4]티아제핀-11-온의 제조방법
WO2004093816A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
WO2004093813A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
DE102004013678A1 (de) * 2004-03-18 2005-10-20 Micronas Gmbh Vorrichtung zur Detektion eines Gases oder Gasgemischs
KR101233139B1 (ko) * 2011-04-21 2013-02-21 주식회사 한서켐 라세믹 1,4-티아제핀 화합물의 분할 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
BR6915295D0 (pt) * 1969-01-25 1973-04-12 Tanabe Seiyaku Co Indicador cronologico de evento em transmissao televisada
JPS5899471A (ja) * 1981-12-07 1983-06-13 Tanabe Seiyaku Co Ltd ベンゾチアゼピン誘導体の新規製造法
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
IT1206505B (it) * 1983-07-22 1989-04-27 Schiapparelli Farma Nuovi derivati benzotiazepinonici, metodo per la loro preparazione e composizioni farmaceutiche che licontengono.
US4490292A (en) * 1983-10-07 1984-12-25 Hamari Chemicals, Ltd. 1,5-Benzothiazepine derivatives and production thereof
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
IL71538A (en) * 1984-04-13 1987-07-31 Abic Ltd Process for the preparation of benzothiazepine derivatives
IE61939B1 (en) * 1987-07-31 1994-11-30 Tanabe Seiyaku Co Naphthothiazepine derivatives and a process for preparing the same

Also Published As

Publication number Publication date
AU594124B2 (en) 1990-03-01
HUT45241A (en) 1988-06-28
AU6925587A (en) 1987-08-27
HU197732B (en) 1989-05-29
NO870782L (no) 1987-08-27
FI870796A0 (fi) 1987-02-24
EP0234561A3 (en) 1988-04-06
IL81676A0 (en) 1987-09-16
KR870007905A (ko) 1987-09-22
MC1792A1 (fr) 1987-10-22
PT84358B (pt) 1989-11-10
DK93787D0 (da) 1987-02-24
US4652561A (en) 1987-03-24
FI870796A (fi) 1987-08-27
NO167285B (no) 1991-07-15
PH23214A (en) 1989-06-06
NZ219386A (en) 1990-06-26
CA1272717A (en) 1990-08-14
PT84358A (en) 1987-03-01
KR900003369B1 (ko) 1990-05-16
NO167285C (no) 1991-10-23
JPS62205067A (ja) 1987-09-09
DK93787A (da) 1987-08-27
ZA871144B (en) 1987-10-28
EP0234561A2 (en) 1987-09-02
NO870782D0 (no) 1987-02-25

Similar Documents

Publication Publication Date Title
PH21850A (en) Dialkoxypyridines,their use and medicaments containing them
DE3368610D1 (en) Phenyl-1-piperidino-2-propanol derivatives, their preparation and medicaments containing them
OA08707A (en) Tertiary hydroxyalkylxanthines, processes for their preparation, medicaments containing them and their use.
IL83198A0 (en) Benzenesulphonamidoindanyl derivatives,their preparation and medicaments containing them
IL83509A0 (en) Pyrimidine derivatives,their manufacture and medicaments containing them
IL84041A (en) Retinoids,their manufacture and pharmaceutical compositions containing them
NZ222843A (en) Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
IL81676A (en) Naphthothiazepinones,their manufacture and medicaments containing them
ZA854287B (en) Dialkoxypyridines,process for their preparation,their use and medicaments containing them
AR242389A1 (es) Procedimiento para preparar -di-(n-alquil c1-c4)-amino-4,5-dihidroimidazo¡1,2-a¿quinazolin-2(1h)-onas.
IL81546A0 (en) Purine derivatives,their production and medicaments containing them
IL81355A0 (en) 8alpha-acylaminoergolines,their production and pharmaceutical compositions containing them
PH23591A (en) Medicaments
GB8625326D0 (en) Medicaments
IL81954A0 (en) Naphthothiazocinones,their manufacture and pharmaceutical compositions containing them
NZ221769A (en) Medicaments containing sialocylglycerolipid
GB8625327D0 (en) Medicaments
GB8627883D0 (en) Medicaments
ZA879457B (en) Medicaments
GB8630083D0 (en) Medicaments
GB8630082D0 (en) Medicaments
GB8630081D0 (en) Medicaments
GB8602260D0 (en) Medicaments
GB8630078D0 (en) Medicaments
GB8630077D0 (en) Medicaments